Fahmy G. Elsaid

According to our database, Fahmy G. Elsaid authored at least 3 papers in 2022.

Collaborative distances:

• Dijkstra number of six.
• Erdős number of six.

2022

Design, Synthesis, and In Vitro Antiproliferative Screening of New Hydrazone Derivatives Containing cis-(4-Chlorostyryl) Amide Moiety.

Tarfah Al-Warhi, Leena S. Alqahtani, Matokah M. Abualnaja, Saba Beigh, Ola A. Abu Ali, Fahmy G. Elsaid, Ali A. Shati, Rasha Mohammed Saleem, Ali Hassan Ahmed Maghrabi, Amani Abdulrahman Alharthi, Amal Alyamani, Eman Fayad, Ali H. Abu Almaaty, Islam Zaki, Shaimaa Hamouda

Symmetry, November, 2022

Design, Synthesis and Cytotoxicity Screening of New Thiazole Derivatives as Potential Anticancer Agents through VEGFR-2 Inhibition.

Tarfah Al-Warhi, Matokah M. Abualnaja, Ola A. Abu Ali, Najiah M. Alyamani, Fahmy G. Elsaid, Ali A. Shati, Sarah Albogami, Eman Fayad, Ali H. Abu Almaaty, Khaled O. Mohamed, Wael M. Alamoudi, Islam Zaki

Symmetry, 2022

Design, Synthesis, and Investigation of Cytotoxic Activity of cis-Vinylamide-Linked Combretastatin Analogues as Potential Anticancer Agents.

Tarfah Al-Warhi, Leena S. Alqahtani, Ghadi Alsharif, Matokah M. Abualnaja, Ola A. Abu Ali, Safa H. Qahl, Hussam Awwadh E. Althagafi, Fahad Alharthi, Ibrahim Jafri, Fahmy G. Elsaid, Ali A. Shati, Salman Aloufi, Eman Fayad, Islam Zaki, Martha M. Morcoss

Symmetry, 2022